Vicapsys Life Sciences, Inc.

OTCPK:VICP Stock Report

Market Cap: US$32.0

Vicapsys Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Fred Pier

Chief executive officer

US$250.0k

Total compensation

CEO salary percentage100.0%
CEO tenure4.3yrs
CEO ownership1.9%
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Fred Pier's remuneration changed compared to Vicapsys Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$250kUS$250k

-US$1m

Sep 30 2023n/an/a

-US$1m

Jun 30 2023n/an/a

-US$988k

Mar 31 2023n/an/a

-US$1m

Dec 31 2022US$120kUS$120k

-US$988k

Sep 30 2022n/an/a

-US$600k

Jun 30 2022n/an/a

-US$562k

Mar 31 2022n/an/a

-US$454k

Dec 31 2021US$90kUS$90k

-US$237k

Sep 30 2021n/an/a

-US$214k

Jun 30 2021n/an/a

-US$192k

Mar 31 2021n/an/a

-US$351k

Dec 31 2020US$180kUS$90k

-US$766k

Sep 30 2020n/an/a

-US$935k

Jun 30 2020n/an/a

-US$1m

Mar 31 2020n/an/a

-US$1m

Dec 31 2019US$60kn/a

-US$1m

Compensation vs Market: Fred's total compensation ($USD250.00K) is below average for companies of similar size in the US market ($USD650.86K).

Compensation vs Earnings: Fred's compensation has increased whilst the company is unprofitable.

CEO

Fred Pier (56 yo)

4.3yrs

Tenure

US$250,000

Compensation

Mr. Federico Pier, also known as Fred, serves as Chief Executive Officer at Vicapsys Life Sciences, Inc. since February 15, 2022 and served as its Interim Chief Executive Officer August 2020 until February...

Board Members

NamePositionTenureCompensationOwnership
Federico Pier
CEO, Executive Chairman & Interim President5.6yrsUS$250.00k1.89%
$ 0.6
Richard Rosenblum
Independent Director2.3yrsno datano data
Charles Farrahar
Independent Director10.3yrsUS$79.43k1.4%
$ 0.4
Colleen Delaney
Independent Director2.3yrsno datano data
Dorothy Jordan
Directorno datano data0.35%
$ 0.1

3.9yrs

Average Tenure

63yo

Average Age

Experienced Board: VICP's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:15
End of Day Share Price 2024/12/10 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vicapsys Life Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution